Imaging Hemodynamics The Next Frontier for CMR∗ by Rademakers, Frank E. & Claus, Piet
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 7 , N O . 9 , 2 0 1 4
ª 2 0 1 4 B Y T H E A M E R I C A N CO L L E G E O F C A R D I O L O G Y F O U N DA T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c m g . 2 0 1 4 . 0 6 . 0 1 1EDITORIAL COMMENTImaging Hemodynamics
The Next Frontier for CMR*Frank E. Rademakers, MD, PHD, Piet Claus, PHDSEE PAGE 920E chocardiography is the work horse of clinicalcardiac imaging, not only because it is rela-tively cheap to operate, mobile, and versatile,
but also because it combines insight into structure
and function as well as into hemodynamics through
the use of Doppler. This feature of echocardiography
was subsequently translated into velocity measure-
ments of the walls of the heart and has contributed
signiﬁcantly to our understanding of the mechanics
and function of the heart. One major limitation of
tissue Doppler was the necessity for alignment of
the interrogating beam with the heart wall under
study. With faster computing power, speckle tracking
became feasible, which overcame this alignment
problem and held the promise for 3-dimensional
(3D) tracking of heart motion and deformation. The
robustness of 3D deformation imaging still requires
improvement, and there is a lack of standardization
of the different vendors’ feature tracking techniques,
which operate more as black boxes. Notwithstanding
these limitations, 3D echocardiography as a whole has
gained much use for the evaluation of valvular and
congenital abnormalities (1).
Cardiac magnetic resonance (CMR) is often used as
an alternative to echocardiography in those patients
who have suboptimal image quality, which can
reach between 10% and 30%, depending on the
indication and target population. CMR is also the
reference technique for structure (and function)
and has major applications in tissue characterization,
which are now being expanded by the use of T1
and T2 mapping and extracellular volume calcula-
tion; it is lacking, however, in easy assessment of*Editorials published in JACC: Cardiovascular Imaging reﬂect the views
of the authors and do not necessarily represent the views of JACC:
Cardiovascular Imaging or the American College of Cardiology.
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contents of this paper to disclose.regional/segmental function and in hemodynamic
evaluation. Valvular evaluation is possible with
CMR but is relatively underused because analysis of
gradients over stenotic valves, arteries, or other
structures is not available.Velocity measurements have always been possible
with CMR but were not used in routine clinical studies.
The paper by Riesenkampff et al. (2) in this issue of
iJACC could change this, because the application
of 4-dimensional velocity measurements toward
calculation of gradients over a coarctation could also
be used across valves and, thus, may become the CMR
equivalent of echocardiography Doppler. Moving
beyond that comparison, as the velocities can be ac-
quired in full 3D, CMR could be better than Doppler
in elucidating cardiac hemodynamics. CMR velocity
measurements in the walls can yield similar informa-
tion as tissue Doppler, and much of the feature
tracking used in echocardiography can be applied
quite easily to CMR images. Combining wall me-
chanics and hemodynamics with cavity measure-
ments to assess blood–wall interaction could become
a very powerful means of better understanding
and, therefore, better treating cardiac and vascular
abnormalities.
Yet, is the promise raised by this paper real?
Riesenkampff et al. (2) demonstrate the feasibility of
an accurate noninvasive assessment of the pressure
drop over an aortic coarctation. The derivation
of pressure ﬁelds and hemodynamic parameters
from velocity measurements always requires compu-
tational models. These can be fairly simple and direct
applicable laws of physics, such as the well-known
Bernoulli equation in echocardiographic Doppler he-
modynamics. More extensive analyses are based on
ﬁnite-element methods solving the Navier-Stokes
equations (or simpliﬁcations such as the Pressure-
Poisson equation in La Disa et al. [3]) in a speciﬁc
anatomical domain. These solutions will depend
highly on the imposed boundary conditions that
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928describe the hemodynamic behavior at the bound-
aries, typically at the inlet and outlet, but also at the
walls. These conditions can be given as velocity and
pressure ﬁelds or as the relations between them There
is no doubt that an accurate measurement of spatially-
and temporally-resolved 4-dimensional velocity-
encoded phase-contrast CMR is a major step forward
to describe the ﬂow ﬁelds. The relation between ﬂow
and pressure at the inlet and outlets are usually
deﬁned by Windkessel models, with characteristic
resistances and capacitances for all of the branching
vessels. Indeed, to hemodynamically completely
characterize a coarctation, themain branching into the
innominate, left carotid, and left subclavian artery and
descending aorta have to be modeled, each with its
own characteristicWindkessel (3). In an ideal scenario,
a coupling to the complete circulation would be
favorable. For example, the presence of a collateral
network from subclavian arteries to the descending
aorta (not taken into account in the paper by Rie-
senkampff et al. [2]) would completely change the re-
sults of these analyses. This is the case in severe native
coarctation of the aorta, which was not the target pa-
tient population in the paper byRiesenkampff et al. (2).
The results from these models will also depend on
the accuracy with which one can build computational
meshes from anatomical imaging. For the aorta,
contrast-enhanced magnetic resonance angiography
has been used extensively. However, as rightfully
explained by Riesenkampff et al. (2), although a
reasonably accurate delineation of the boundary is
possible, accurate measurements of the 3D velocity
vectors at the boundaries is currently beyond the
resolution of the technique. This hampers an accurate
measurement of the blood–wall interaction. As a
consequence, shear stress measurements rely on a
number of assumptions of the behavior of blood near
the wall, and are thus “modeled.” In smooth vessels
with reasonable laminar ﬂow conditions, these as-
sumptions are probably close to reality. To date, there
is little validation of these measurements in more
complicated situations where nonlaminar ﬂow is
present. To reliably quantify the interaction between
blood and wall, the mechanical properties of the
vessel walls also have to be known. This information
is still only sparsely available for pathological vessel
walls. Nonetheless, stable computational frameworks
have been built to study these interactions (4).
Although the derivation of pressure ﬁelds in the
setting of an aortic coarctation is feasible from a CMR
and a simulation perspective, the previous descrip-
tion of the ingredients necessary for a complete
hemodynamic characterization including blood–
tissue interactions clearly shows that, for otherapplications like valve hemodynamics, some further
progress will be needed. Four-dimensional velocity-
encoded CMR covering the complete heart is a major
step forward in the assessment of ventricular ﬂow
ﬁelds and can now be assessed in a reasonable time.
However, compared with the aorta, the ventricles are
highly deforming structures, and an accurate time-
resolved anatomical model of the ventricle from
CMR remains challenging. Moreover, fast-moving
thin structures like valve leaﬂets are not easy to
segment on CMR images. This makes the meshing
problem much more complicated compared with the
aorta. Besides accurate anatomical mesh generation,
the noninvasive estimation of absolute intracardiac
pressures remains challenging, which in diastole
mostly requires combination of ventricular wall
properties and blood ﬂow, increasing the number
of unknowns in the model-based estimations.
Again, pathological myocardial mechanical properties
remain a big unknown, but (contrast-enhanced)
myocardial mapping techniques (T1, T2/T2*) could
provide data on regional heterogeneity.
Finally, there is the question of value: improved
outcome for patients at a similar or lower cost for
society. Does this new capability of CMR respond to a
nonanswered question from a patient perspective?
Although this new attribute could be seen as a very
nice addition to CMR as a “1-stop-shop,” the question
remains whether that is the right approach. Rather
than pushing new technical capabilities into clinical
practice, perhaps we should be better deﬁning the
remaining unresolved questions and looking for
speciﬁc answers in a clinical-pathway perspective,
where care is provided at the most appropriate level.
This does not mean that we should not pursue tech-
nical improvements and research their applications to
clinical care, but we should not add such innovations
into regular clinical practice unless they replace
another methodology, with proven better manage-
ment and outcome for patients at similar or lower
cost. Besides showing good sensitivity, speciﬁcity,
and accuracy for the clinical parameters under study,
an imaging modality should also impact the managing
of patients and improve their outcomes before being
widely adopted. An imaging platform could be a
possible answer to the value proposition: the clinician
poses a speciﬁc question and the platform, all
imagers—cardiologists, nuclear physicians, and radi-
ologists in collaboration—decide on the most appro-
priate modality for that speciﬁc patient and question,
and after doing the required studies, there is an
integrated report answering the original question—all
within a deﬁned budget for that type of clinical
question or care pathway (5).
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929If and when CMR velocity-derived hemodynamic
information will be included in regular clinical prac-
tice will require further technical advances and
“value” testing, but from a research perspective, it
could become a major technique combining within 1
acquisition wall, valve, and cavity motion, defor-
mation, ﬂow, and hemodynamic information thatallows a very comprehensive analysis of normal and
abnormal physiology.
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